Literature DB >> 25430416

Dissecting chronic lymphocytic leukemia microenvironment signals in patients with unmutated disease: microRNA-22 regulates phosphatase and tensin homolog/AKT/FOXO1 pathway in proliferative leukemic cells.

Florencia Palacios1, Daniel Prieto, Cecilia Abreu, Santiago Ruiz, Pablo Morande, Tamara Fernández-Calero, Gabriela Libisch, Ana Inés Landoni, Pablo Oppezzo.   

Abstract

Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of clonal B cells arrested in G0/G1 stages that coexist with proliferative B cells. We identified one of these proliferative subsets in the peripheral blood from patients with unmutated disease (UM). Aiming to characterize the molecular mechanism underlying this proliferative behavior, we performed gene expression analysis of the mRNA and microRNAs in this leukemic subpopulation and compared results with those for the quiescent counterpart. Our results suggest that proliferation of this subset mainly depends on microRNA-22 overexpression, which induces phosphatase and tensin homolog (PTEN) down-regulation and phosphoinositide 3-kinase (PI3K)/AKT pathway activation. These results underline the role of the PI3K/AKT pathway at the origin of this proliferative pool in patients with UM CLL and provide additional rationale for the use of PI3K inhibitors.

Entities:  

Keywords:  CLL microenvironment signals; unmutated patients

Mesh:

Substances:

Year:  2015        PMID: 25430416     DOI: 10.3109/10428194.2014.990900

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  6 in total

1.  Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia.

Authors:  L M Saleh; W Wang; S E M Herman; N S Saba; V Anastas; E Barber; M Corrigan-Cummins; M Farooqui; C Sun; S M Sarasua; Z Zhao; N K Abousamra; O Elbaz; H A Abdelghaffar; A Wiestner; K R Calvo
Journal:  Leukemia       Date:  2016-06-24       Impact factor: 11.528

2.  Ibrutinib therapy downregulates AID enzyme and proliferative fractions in chronic lymphocytic leukemia.

Authors:  Pablo Elías Morande; Mariela Sivina; Angimar Uriepero; Noé Seija; Catalina Berca; Pablo Fresia; Ana Inés Landoni; Javier M Di Noia; Jan A Burger; Pablo Oppezzo
Journal:  Blood       Date:  2019-02-27       Impact factor: 25.476

Review 3.  MiRNA-based therapeutic intervention of cancer.

Authors:  Srivatsava Naidu; Peter Magee; Michela Garofalo
Journal:  J Hematol Oncol       Date:  2015-06-11       Impact factor: 17.388

Review 4.  The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.

Authors:  Xiaoxiao Wang; Huiqiang Huang; Ken H Young
Journal:  Aging (Albany NY)       Date:  2015-12       Impact factor: 5.682

Review 5.  MicroRNAs as Biomarkers of B-cell Lymphoma.

Authors:  Carla Solé; Esther Arnaiz; Charles H Lawrie
Journal:  Biomark Insights       Date:  2018-10-16

6.  Statins induce cell apoptosis through a modulation of AKT/FOXO1 pathway in prostate cancer cells.

Authors:  Jun-Li Deng; Rui Zhang; Ying Zeng; Yuan-Shan Zhu; Guo Wang
Journal:  Cancer Manag Res       Date:  2019-07-31       Impact factor: 3.989

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.